Strobel J L, Baynes J W, Thorpe S R
Arch Biochem Biophys. 1985 Aug 1;240(2):635-45. doi: 10.1016/0003-9861(85)90071-2.
Residualizing radioactive labels are designed to remain entrapped within cells following degradation of a carrier protein, and have been used for identification of the tissue and cellular sites of plasma protein catabolism. In this study we describe a convenient synthesis and purification of a series of 125I-labeled glycoconjugates, and an evaluation of their efficiency of retention in liver following degradation of a model carrier protein, asialofetuin. Glycoconjugates were prepared in 65-90% yield by reductive amination of reducing sugars with aromatic amines using NaBH3CN. The products were purified in a single ion-exchange chromatographic step, and then labeled with 125I. The derivatives prepared were mono-and disubstituted lactitol-,cellobiitol-and glucitol-[125I]tyramine and lactitol-[125I]tyrosine. 125I-Glycoconjugates were coupled to asialofetuin using either cyanuric chloride or, for lactose-containing labels, by treatment with galactose oxidase followed by reductive amination with NaBH3CN. Attachment of labels by either procedure did not affect the normal rapid clearance of asialofetuin from the rat circulation nor its uptake and degradation in liver lysosomes. Leakage of 125I-labeled degradation products from cells was measured by following the kinetics of loss of whole-body radioactivity. We observed that degradation products from larger, disubstituted glycoconjugates were retained more efficiently than those from smaller and monosubstituted derivatives, and that glycoconjugates coupled to protein via reductive amination were retained in the body more efficiently than those coupled by cyanuric chloride. Overall, dilactitol-[125I]tyramine coupled to protein by reductive amination was entrapped most efficiently in liver.
残留放射性标记物旨在在载体蛋白降解后仍滞留在细胞内,已被用于鉴定血浆蛋白分解代谢的组织和细胞部位。在本研究中,我们描述了一系列125I标记的糖缀合物的简便合成和纯化方法,以及对它们在模型载体蛋白去唾液酸胎球蛋白降解后在肝脏中的保留效率的评估。通过使用NaBH3CN将还原糖与芳香胺进行还原胺化反应,以65 - 90%的产率制备糖缀合物。产物通过一步离子交换色谱法纯化,然后用125I进行标记。所制备的衍生物是单取代和双取代的乳糖醇 - 、纤维二糖醇 - 和葡糖醇 - [125I]酪胺以及乳糖醇 - [125I]酪氨酸。125I - 糖缀合物使用三聚氯氰与去唾液酸胎球蛋白偶联,或者对于含乳糖的标记物,先用半乳糖氧化酶处理,然后用NaBH3CN进行还原胺化反应。通过这两种方法进行标记均不影响去唾液酸胎球蛋白在大鼠循环中的正常快速清除,也不影响其在肝溶酶体中的摄取和降解。通过跟踪全身放射性的损失动力学来测量125I标记的降解产物从细胞中的泄漏情况。我们观察到,较大的双取代糖缀合物的降解产物比较小的单取代衍生物的降解产物保留效率更高,并且通过还原胺化与蛋白质偶联的糖缀合物在体内的保留效率比通过三聚氯氰偶联的更高。总体而言,通过还原胺化与蛋白质偶联的二乳糖醇 - [125I]酪胺在肝脏中的截留效率最高。